Inventor · disambiguated record
Seth M. Cohen
Also filed as: COHEN SETH · COHEN SETH M
17 granted patents·10 pending applications·347 citations·filing 2000–2018
94Inventor score
Files withUNIV CALIFORNIA17COHEN SETH M3BURNHAM INST MEDICAL RESEARCH1CALIFORNIA INST OF TECHN1CANCER RES INST1
Top patents by PatentIndex Score
27 records- 0198US6515113B2Phthalamide lanthanide complexes for use as luminescent markersUNIV CALIFORNIA·Filed 2000·Granted Feb 4, 2003·91 cites·5 claims
- 0295US6406297B1Salicylamide-lanthanide complexes for use as luminescent markersUNIV CALIFORNIA·Filed 2000·Granted Jun 18, 2002·90 cites·5 claims
- 0393US7579486B2Metalloprotein inhibitorsUNIV CALIFORNIA SAN DIEGO·Filed 2006·Granted Aug 25, 2009·22 cites·5 claims
- 0491US7786316B2Metalloprotein inhibitorsUNIV CALIFORNIA·Filed 2009·Granted Aug 31, 2010·12 cites·4 claims
- 0591US7018850B2Salicylamide-lanthanide complexes for use as luminescent markersUNIV CALIFORNIA·Filed 2002·Granted Mar 28, 2006·49 cites·98 claims
- 0691US6864103B2Phthalamide-lanthanide complexes for use as luminescent markersUNIV CALIFORNIA·Filed 2001·Granted Mar 8, 2005·37 cites·67 claims
- 0787US7404912B2Salicylamide-lanthanide complexes for use as luminescent markersUNIV CALIFORNIA·Filed 2006·Granted Jul 29, 2008·11 cites·9 claims
- 0886US7705164B2Metalloprotein inhibitorsUNIV CALIFORNIA·Filed 2005·Granted Apr 27, 2010·6 cites·9 claims
- 0986US7442558B2Phthalamide-lanthanide complexes for use as luminescent markersUNIV CALIFORNIA·Filed 2004·Granted Oct 28, 2008·16 cites·19 claims
- 1085US10201803B2Polymer-metal organic framework materials and methods of using the sameUNIV CALIFORNIA·Filed 2016·Granted Feb 12, 2019·4 cites·19 claims
- 1179US8008510B2Metalloprotein inhibitorsUNIV CALIFORNIA·Filed 2010·Granted Aug 30, 2011·3 cites·6 claims
- 1276US8318945B2Metalloprotein inhibitorsPUERTA DAVID T·Filed 2011·Granted Nov 27, 2012·2 cites·6 claims
- 1366US10005735B2Inhibitors of RPN11CALIFORNIA INST OF TECHN·Filed 2016·Granted Jun 26, 2018·1 cites·18 claims
- 1465US9598383B2Reactive oxygen species-based prodrugsUNIV CALIFORNIA·Filed 2014·Granted Mar 21, 2017·1 cites·4 claims
- 1563US2010041653A1Composition and methods for the design and development of metallo-enzyme inhibitorsBURNHAM INST MEDICAL RESEARCH·Filed 2009·Application pending·0 cites
- 1662US2008293155A1Salicylamide-lanthanide complexes for use as luminescent markersUNIV CALIFORNIA·Filed 2008·Application pending·0 cites
- 1759US8889638B2Stimulus-triggered prodrugsCOHEN SETH M·Filed 2011·Granted Nov 18, 2014·2 cites·7 claims
- 1852US2014142137A1Hiv integrase inhibitorsNAT INST HEALTH·Filed 2013·Application pending·0 cites
- 1944US2014248218A1Ros-sensitive fluorescent probesUNIV CALIFORNIA·Filed 2014·Application pending·0 cites
- 2043US2015218120A1Hiv integrase inhibitorsUNIV CALIFORNIA·Filed 2015·Application pending·0 cites
- 2142US2010098640A1Multidentate Pyrone-Derived Chelators for Medicinal Imaging and ChelationCOHEN SETH M·Filed 2006·Application pending·0 cites
- 2241US2012135959A1Metalloprotein inhibitors containing nitrogen based ligandsCOHEN SETH M·Filed 2007·Application pending·0 cites
- 2341US2014235548A1Compositions and methods for jamm protein inhibitionCLEAVE BIOSCIENCES INC·Filed 2012·Application pending·0 cites
- 2440US10889556B2Compositions and methods for inhibiting influenza RNA polymerase PA endonucleaseUNIV CALIFORNIA·Filed 2018·Granted Jan 12, 2021·0 cites·16 claims
- 2539US2009023928A1Phthalamide-lanthanide complexes for use as luminescent markersUNIV CALIFORNIA·Filed 2008·Application pending·0 cites
- 2635US2017088532A1Inhibitors of lpxcUNIV CALIFORNIA·Filed 2016·Application pending·0 cites
- 2731US9320736B2Zinc chelating agents for depleting XIAP and sensitizing tumor cells to apoptosisCANCER RES INST·Filed 2015·Granted Apr 26, 2016·0 cites·18 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →